We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.3B
AUM Growth
+$479M
Cap. Flow
-$13.7M
Cap. Flow %
-0.32%
Top 10 Hldgs %
47.06%
Holding
186
New
16
Increased
26
Reduced
83
Closed
3

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$5.46M
2
FERG icon
Ferguson
FERG
+$3.54M
3
OWL icon
Blue Owl Capital
OWL
+$3.32M
4
FTRE icon
Fortrea Holdings
FTRE
+$3M
5
SCHW
Charles Schwab
SCHW
+$2.76M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$7.68M
2
WMS icon
Advanced Drainage Systems
WMS
+$7.19M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.95M
4
MSFT icon
Microsoft
MSFT
+$5.14M
5
MA icon
Mastercard
MA
+$3.07M

Sector Composition

Rank Sector Weight
1 Financials 40.69%
2 Healthcare 13.57%
3 Technology 12.87%
4 Communication Services 7.57%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AB icon
151
AllianceBernstein
AB
$3.47B
$238K 0.01%
7,658
– –
AZN icon
152
AstraZeneca
AZN
$269B
$233K 0.01%
1,732
– –
MS icon
153
Morgan Stanley
MS
$319B
$233K 0.01%
2,500
– –
AMT icon
154
American Tower
AMT
$83.5B
$229K 0.01%
+1,063
New +$201K
DXCM icon
155
DexCom
DXCM
$29B
$226K 0.01%
+1,818
New +$186K
SPY icon
156
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$225K 0.01%
473
-1,350
-74% -$601K
ELV icon
157
Elevance Health
ELV
$81.5B
$222K 0.01%
+471
New +$218K
VRCA icon
158
Verrica Pharmaceuticals
VRCA
$89M
$220K 0.01%
3,000
– –
BA icon
159
Boeing
BA
$169B
$216K 0.01%
+830
New +$178K
MRSH
160
Marsh
MRSH
$94.3B
$212K ﹤0.01%
1,120
– –
WBS icon
161
Webster Financial
WBS
$12.3B
$208K ﹤0.01%
+4,091
New +$177K
QQQ icon
162
Invesco QQQ Trust
QQQ
$436B
$205K ﹤0.01%
500
-100
-17% -$38K
TMM
163
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$170K ﹤0.01%
236,797
-1,436
-0.6% -$1.03K
SJT
164
San Juan Basin Royalty Trust
SJT
$119M
$117K ﹤0.01%
22,980
-800
-3% -$5.35K
VTRS icon
165
Viatris
VTRS
$20.8B
$116K ﹤0.01%
10,667
-3
-0% -$29
RIG icon
166
Transocean
RIG
$5.48B
$63.5K ﹤0.01%
10,000
– –
AMRN
167
Amarin Corp
AMRN
$297M
$26.1K ﹤0.01%
1,500
– –
VCMP
168
DELISTED
VCAMPUS CORP
VCMP
$15 ﹤0.01%
59,956
– –
GIS icon
169
General Mills
GIS
$20.2B
– –
-6,000
Closed -$384K
WLY icon
170
John Wiley & Sons Class A
WLY
$2.83B
– –
-5,575
Closed -$207K
MIMO
171
DELISTED
Airspan Networks Holdings Inc
MIMO
– –
-80,000
Closed -$12K
3 4 5 6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2023 Portfolio in Review

As of Q4 2023, Beck Mack & Oliver held 186 positions worth $4.3B, up 13% from $3.82B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver's Q4 2023 filing shows 16 new, 26 increased, 83 reduced and 3 closed positions. Its largest new stake was CVS Health: 21,339 shares worth $1.68M. The largest sale was Sherwin-Williams, an estimated $7.68M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2023 buy was CVS Health: 21,339 shares worth $1.68M.
  • Beck Mack & Oliver added most to Rush Enterprises Class A in Q4 2023, an estimated $5.46M increase.
  • Beck Mack & Oliver's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $7.68M.
  • Beck Mack & Oliver fully exited General Mills in Q4 2023, selling an estimated $384K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.3B portfolio in Q4 2023.
  • Beck Mack & Oliver opened 16 new positions and closed 3 in Q4 2023.
  • Beck Mack & Oliver's portfolio value rose 13% quarter-over-quarter to $4.3B.

Based on Beck Mack & Oliver's 13F filing for Q4 2023, filed 14 Feb 2024.